Andrew Jacob Silver insider trades
Open-market stock purchases and sales by Andrew Jacob Silver, Chief Financial Officer at CRISPR Therapeutics AG, from SEC Form 4 filings since Oct 19, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
Companies traded
- CRSP CRISPR Therapeutics AG: other filings, last Oct 19, 2026
Get free alerts when Andrew Jacob Silver files a new trade →